BRPI0818723A2 - composição, alimento funcional, fórmula infantil, métodos para melhorar, promover ou manter o desenvolvimento de funções cognitivas em um bebê, o desenvolvimento de cérebro e retina em um bebê, o desenvolvimento de acuidades visuais em um bebê, a qualidade de crescimento de um bebê, o desenvolvimento do sistema nervoso central em um bebê, e maturidade intestinal em bebês, para reduzir peroxidação de lipídio em um bebê, e para aumentar absorção intestinal de ácidos graxos ômega-3 e/ou ômega-6 em bebês, e, uso de uma composição - Google Patents

composição, alimento funcional, fórmula infantil, métodos para melhorar, promover ou manter o desenvolvimento de funções cognitivas em um bebê, o desenvolvimento de cérebro e retina em um bebê, o desenvolvimento de acuidades visuais em um bebê, a qualidade de crescimento de um bebê, o desenvolvimento do sistema nervoso central em um bebê, e maturidade intestinal em bebês, para reduzir peroxidação de lipídio em um bebê, e para aumentar absorção intestinal de ácidos graxos ômega-3 e/ou ômega-6 em bebês, e, uso de uma composição

Info

Publication number
BRPI0818723A2
BRPI0818723A2 BRPI0818723A BRPI0818723A BRPI0818723A2 BR PI0818723 A2 BRPI0818723 A2 BR PI0818723A2 BR PI0818723 A BRPI0818723 A BR PI0818723A BR PI0818723 A BRPI0818723 A BR PI0818723A BR PI0818723 A2 BRPI0818723 A2 BR PI0818723A2
Authority
BR
Brazil
Prior art keywords
infant
development
infants
omega
composition
Prior art date
Application number
BRPI0818723A
Other languages
English (en)
Inventor
Katz Ariel
Pelled Dori
Bar Yosef Fabiana
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40349932&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0818723(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of BRPI0818723A2 publication Critical patent/BRPI0818723A2/pt
Publication of BRPI0818723B1 publication Critical patent/BRPI0818723B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0818723-1A 2007-11-01 2008-11-02 Composição para nutrição infantil BRPI0818723B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99610907P 2007-11-01 2007-11-01
US60/996,109 2007-11-01
PCT/IL2008/001437 WO2009057121A1 (en) 2007-11-01 2008-11-02 Lipid mixture for infant nutrition

Publications (2)

Publication Number Publication Date
BRPI0818723A2 true BRPI0818723A2 (pt) 2017-05-23
BRPI0818723B1 BRPI0818723B1 (pt) 2020-02-27

Family

ID=40349932

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818723-1A BRPI0818723B1 (pt) 2007-11-01 2008-11-02 Composição para nutrição infantil

Country Status (11)

Country Link
US (2) US8975299B2 (pt)
EP (1) EP2230942B1 (pt)
KR (2) KR20150126977A (pt)
CN (2) CN101909467B (pt)
AU (1) AU2008320328B2 (pt)
BR (1) BRPI0818723B1 (pt)
CA (1) CA2704345C (pt)
ES (1) ES2660416T3 (pt)
MX (1) MX2010004820A (pt)
RU (2) RU2611808C2 (pt)
WO (1) WO2009057121A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009057121A1 (en) 2007-11-01 2009-05-07 Enzymotec Ltd. Lipid mixture for infant nutrition
WO2010027259A1 (en) 2008-09-02 2010-03-11 N.V. Nutricia Nutritional compositions with coated lipid globules
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
DK2496092T3 (en) * 2009-11-03 2018-07-16 Dsm Ip Assets Bv COMPOSITION WITH CELLS AND A POLYUM Saturated FAT ACID WITH AT LEAST 20 CARBON ATOMS (LC-PUFA)
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
AU2013221572B2 (en) 2012-02-17 2017-12-21 Alcresta Therapeutics, Inc. Methods, compositions, and devices for supplying dietary fatty acid needs
SE536599C3 (sv) * 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
SG11201507217PA (en) * 2013-03-13 2015-10-29 Abbott Lab Method of enhancing bioavailability of dha and other lipid-soluble nutrients
KR20160041952A (ko) * 2013-08-01 2016-04-18 로더스 크로크란 비.브이. 글리세리드 조성물
ES2693519T3 (es) 2013-11-01 2018-12-12 N.V. Nutricia Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
US9610302B2 (en) 2013-12-05 2017-04-04 Buriva, LLC. Composition containing phospholipid-DHA and B vitamins
US9216199B2 (en) 2013-12-05 2015-12-22 Buriva, LLC Nutritional supplement containing phospholipid-DHA derived from eggs
US9233114B2 (en) 2013-12-05 2016-01-12 Buriva, LLC Dietary supplement containing phospholipid-DHA derived from eggs
US9549937B2 (en) 2013-12-05 2017-01-24 Burvia, LLC. Composition containing phospholipid-DHA and folate
CN105813477A (zh) * 2013-12-12 2016-07-27 雀巢产品技术援助有限公司 用于三个月以下和以上婴儿认知功能健康建立的、包含n-6二十碳三烯酸和极性脂质的合成乳组合物
RU2706202C2 (ru) * 2014-12-23 2019-11-15 Эвоник Дегусса Гмбх Способ повышения устойчивости композиции, содержащей омега-3 полиненасыщенные жирные кислоты
SG11201704399RA (en) * 2014-12-23 2017-07-28 Evonik Degussa Gmbh Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
WO2017009711A1 (en) * 2015-07-13 2017-01-19 Enzymotec Ltd. Phospholipid preparations for the improvement of sleep
US10258590B2 (en) 2015-10-14 2019-04-16 Alcresta Therapeutics, Inc. Enteral feeding device and related methods of use
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
CN105595323A (zh) * 2015-12-02 2016-05-25 北京世纪合辉医药科技股份有限公司 一种磷脂、不饱和脂肪酸复方保健品及其制备方法
MY197734A (en) * 2015-12-14 2023-07-12 Nestle Sa Nutritional compositions and infant formula for promoting de novo myealination
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
US10941385B2 (en) * 2016-09-23 2021-03-09 Wake Forest University Modified microorganisms as sustainable sources of omega-3 polyunsaturated fatty acid production
ES2987545T3 (es) 2016-12-09 2024-11-15 Nutricia Nv Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo
AU2019409528B2 (en) 2018-12-20 2025-04-24 Société des Produits Nestlé S.A. Human milk fortifier composition
BR112022000814A2 (pt) 2019-07-17 2022-03-08 Baker Heart And Diabetes Inst Composição, método de manutenção de éteres lipídicos, método de avaliação de um indivíduo, método de tratamento ou prevenção, método de prevenção de asma, uso de uma composição
MX2022013442A (es) * 2020-04-27 2022-11-30 Nestle Sa Metodo para producir productos similares a la leche.
CN115825294B (zh) * 2023-02-07 2023-05-26 北京三元食品股份有限公司 一种用于评价婴幼儿沟通能力和发育状况的标志物组及应用
CN116008438B (zh) * 2023-02-07 2023-06-06 北京三元食品股份有限公司 一种用于评价婴幼儿精细动作发育状况的标志物组及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0784437T3 (da) 1994-10-05 1999-04-19 Milupa Gmbh & Co Kg Phospholipidholdig fedtblanding med LCP-fedtsyrer
DE19644518A1 (de) 1996-10-25 1998-04-30 Nutricia Nv Wässrige Fettemulsion, diese enthaltende Nahrung und deren Verwendung
EP1039892B1 (en) 1997-02-21 2004-04-28 Abbott Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
US20040143013A1 (en) * 2000-02-28 2004-07-22 Bristol-Myers Squibb Company Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants
AU2002309856B2 (en) 2001-05-14 2008-10-23 Dsm Ip Assets B.V. Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
US7396548B2 (en) 2002-03-19 2008-07-08 Advanced Bionutrition Corporation Microalgal feeds containing arachidonic acid and their production and use
US20050129738A1 (en) * 2002-06-16 2005-06-16 Lipogen Ltd. Infant formula supplemented with phospholipids
CN1842277A (zh) 2003-06-24 2006-10-04 堪萨斯大学医学中心 婴儿配方食品
IL158552A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Lipids containing omega-3 fatty acids
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
TWI365716B (en) 2003-12-02 2012-06-11 Suntory Holdings Ltd Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same
EP1634599A1 (en) * 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
US20060229366A1 (en) 2005-04-07 2006-10-12 Lifschitz Carlos H Method for preventing or treating respiratory infections in infants
ES2537080T3 (es) * 2005-12-23 2015-06-02 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas y manganeso y/o molibdeno para mejorar la composición de membranas celulares
BRPI0818079B8 (pt) * 2007-10-09 2021-07-27 Enzymotec Ltd composição de lipídeo
WO2009057121A1 (en) 2007-11-01 2009-05-07 Enzymotec Ltd. Lipid mixture for infant nutrition

Also Published As

Publication number Publication date
CA2704345A1 (en) 2009-05-07
KR101597372B1 (ko) 2016-02-24
RU2488283C2 (ru) 2013-07-27
EP2230942B1 (en) 2018-01-10
CA2704345C (en) 2016-07-26
MX2010004820A (es) 2010-08-10
RU2010122055A (ru) 2011-12-10
CN101909467A (zh) 2010-12-08
KR20100094490A (ko) 2010-08-26
US20100298273A1 (en) 2010-11-25
US8975299B2 (en) 2015-03-10
AU2008320328A1 (en) 2009-05-07
EP2230942A1 (en) 2010-09-29
WO2009057121A1 (en) 2009-05-07
ES2660416T3 (es) 2018-03-22
RU2611808C2 (ru) 2017-03-01
AU2008320328B2 (en) 2014-10-02
KR20150126977A (ko) 2015-11-13
CN103202353A (zh) 2013-07-17
CN101909467B (zh) 2013-04-24
RU2013116385A (ru) 2014-10-20
BRPI0818723B1 (pt) 2020-02-27
US20150148316A1 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
BRPI0818723A2 (pt) composição, alimento funcional, fórmula infantil, métodos para melhorar, promover ou manter o desenvolvimento de funções cognitivas em um bebê, o desenvolvimento de cérebro e retina em um bebê, o desenvolvimento de acuidades visuais em um bebê, a qualidade de crescimento de um bebê, o desenvolvimento do sistema nervoso central em um bebê, e maturidade intestinal em bebês, para reduzir peroxidação de lipídio em um bebê, e para aumentar absorção intestinal de ácidos graxos ômega-3 e/ou ômega-6 em bebês, e, uso de uma composição
WO2013068879A3 (en) Infant formula with high sn-2 palmitate and oligofructose
NZ613165A (en) Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof
EP4382108A3 (en) Synergistic production of butyrate associated with the complexity of hmos blend for use in infants or young children for health purposes
MY175195A (en) Nutritional compositions
BRPI1013013A2 (pt) "composição nutricional para suporte do desenvolvimento cerebral e função de criança"
BR112014019927B8 (pt) Fórmula nutricional, seu método de preparação, seu uso, dispositivos e composição
BR112014008511A2 (pt) composições nutricionais com fitonutrientes
BRPI1011089A2 (pt) Composição nutricional para estimular o desenvolvimento e a função cerebral de crianças.
MX2013007691A (es) Productos nutricionales que incluyen un sistema de grasa novedoso que incluye monogliceridos.
CO6420320A2 (es) Productos que comprenden amidas de n-fenilpropenoil amino ácido y usos de los mismos
PH12016500991B1 (en) Liquid milk fortifier composition with relatively high lipid content
BR112013024189A2 (pt) métodos para aprimorar saúde óssea em crianças com o uso de ácidos graxos poli-insaturados de cadeia longa
PH12013500716A1 (en) Age-tailored nutritional composition with animal fats and vegetable fats
BRPI0820116A2 (pt) Produto alimentar incluindo um ou mais ácidos graxos de ômega-3 e um ou mais sabores de fruta
BR112015023011A2 (pt) fórmula para bebês contendo baixa caloria
WO2012004273A3 (en) Array of age-tailored nutritional formula with optimum fat content
PH12017500202A1 (en) Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses
PH12017500632A1 (en) Infant nutrition with hydrolysed protein and palmitic acid
BR112015001794A2 (pt) composição cremosa nutritiva
PH12016501111A1 (en) Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste
HK1198874A1 (zh) 改造膳食的方法
RU2016112528A (ru) Лактоферрин, улучшение памяти и повышение скорости обучения у детей
TH156243A (th) สูตรสำหรับทารกที่มี sn-2 พาลมิเตดสูงและโอลิโกฟรุกโตส
PT2040558E (pt) Produto alimentar lácteo contendo lípidos do sistema nervoso central

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/115 (2016.01), A23L 33/12 (2016.01), A23L

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO DO CODIGO 7.4 NA RPI NO 2461 DE 06/03/2018 POR TER SIDO INDEVIDA, TENDO EM VISTA QUE A MATERIA OBJETO DO PEDIDO DE PATENTE NAO SE ESQUADRA NO ART. 229-C DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/02/2020, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2694 DE 23-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.